Trial Profile
PANDDA Study: Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacokinetics
- Acronyms PANDDA
- 22 Jul 2019 Status changed from not yet recruiting to withdrawn prior to enrolment due to funding issues.
- 24 Jan 2018 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 24 Jan 2018 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.